Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers.

Autor: Zhao, Kun1 (AUTHOR), Zhao, Qi2 (AUTHOR), Dai, Xinzhi3 (AUTHOR), Wen, Xue2 (AUTHOR), Luo, Xing2 (AUTHOR), Duan, Yi2 (AUTHOR), Yang, Zhihui2 (AUTHOR) yzhih73@swmu.edu.cn, Dai, Qiong4 (AUTHOR) 709230152@qq.com
Zdroj: Cancer Cell International. 5/31/2024, Vol. 24 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje